Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$259 | -$246 | -$222 | -$169 |
| Dep. & Amort. | $9 | $7 | $6 | $5 |
| Deferred Tax | $0 | $0 | $0 | $3 |
| Stock-Based Comp. | $44 | $39 | $31 | $29 |
| Change in WC | $2 | $13 | $6 | -$3 |
| Other Non-Cash | -$6 | -$9 | $0 | $14 |
| Operating Cash Flow | -$210 | -$195 | -$178 | -$121 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$16 | -$9 | -$8 |
| Net Acquisitions | $0 | $0 | $43 | $0 |
| Inv. Purchases | -$246 | -$391 | -$376 | -$246 |
| Inv. Sales/Matur. | $383 | $309 | $273 | $272 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | $132 | -$98 | -$69 | $19 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $186 | $208 | $155 | $38 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | -$0 | -$0 |
| Financing Cash Flow | $186 | $208 | $155 | $38 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $108 | -$85 | -$92 | -$65 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57 | $142 | $234 | $299 |
| End Cash | $165 | $57 | $142 | $234 |
| Free Cash Flow | -$216 | -$211 | -$187 | -$129 |